Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
<p><strong>Background</strong> The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19. We aimed to es...
主要な著者: | Butler, CC, Hobbs, FDR, Gbinigie, OA, Rahman, NM, Hayward, G, Richards, DB, Dorward, J, Lowe, DM, Standing, JF, Breuer, J, Khoo, S, Petrou, S, Hood, K, Nguyen-Van-Tam, JS, Patel, MG, Saville, BR, Marion, J, Ogburn, E, Allen, J, Rutter, H, Francis, N, Thomas, NPB, Evans, P, Dobson, M, Madden, T-A, Holmes, J, Harris, V, Png, ME, Lown, M, van Hecke, O, Detry, MA, Saunders, CT, Fitzgerald, M, Berry, NS, Mwandigha, L, Galal, U, Mort, S, Jani, BD, Hart, ND, Ahmed, H, Butler, D, McKenna, M, Chalk, J, Lavallee, L, Hadley, E, Cureton, L, Benysek, M, Andersson, M, Coates, M, Barrett, S, Bateman, C, Davies, JC, Raymundo-Wood, I, Ustianowski, A, Carson-Stevens, A, Yu, L-M, Little, P |
---|---|
その他の著者: | PANORAMIC Trial Collaborative Group |
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2022
|
類似資料
-
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): preliminary analysis from the united kingdom randomised, controlled open-label, platform adaptive trial
著者:: Butler, C, 等
出版事項: (2022) -
Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial
著者:: Png, ME, 等
出版事項: (2024) -
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial
著者:: Butler, CC, 等
出版事項: (2019) -
The problem with usual care.
著者:: Mant, D
出版事項: (2008) -
Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
著者:: RECOVERY Collaborative Group, 等
出版事項: (2024)